Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tricosaccaride is a proprietary cosmetic active ingredient developed by Foltène Pharma, consisting of a mixture of natural mucopolysaccharides. It is designed for topical application to the scalp to address hair loss and thinning. The ingredient works by stimulating natural hair regrowth, strengthening the hair shaft, and normalizing the hair's growth cycle. Biologically, it is reported to improve scalp microcirculation and facilitate intracellular exchanges while assisting in the removal of waste products from the hair follicle. Clinical evaluations have demonstrated its ability to increase the percentage of hair in the anagen (growth) phase and decrease the percentage in the telogen (shedding) phase. It is primarily marketed in various hair care formulations such as vials, foams, and shampoos.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tricosaccaride.